CRDF logo
Cardiff Oncology, Inc.(CRDF)
Last print unknown agoAbout this dataData status
$0.89▼-0.02 (-1.71%)Stale · unknown old

CRDF CapEx to Revenue

12.20%TTM

Retrieved:

CRDF FY CapEx/Revenue%
CRDF FY CapEx/Revenue801.91%-85.92%
2005-01-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CRDF capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 19 observations from Jan 31, 2005 to Dec 31, 2025.

Cardiff Oncology Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.4199%
11.713%
119.2623%
231.0881%
57.1031%
57.6503%
27.7969%
1.3492%
19.802%
216.0105%
715.9955%
129.7464%
250.4509%
60.0178%
0.5929%
10.4444%
1.5385%
0%
0%

Compare capex to revenue

All CRDF financial metrics · CRDF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.